Objective: The purpose of this article is to through the Meta analysis means to observe
vascular endothelial inhibiting hormone (en) in combination with cisplatin compared with …

Objective: To study the efficacy and safety of the intrapleural injection of nedaplatin
combined with recombinant hu-man endostatin (Endostar) in the treatment of malignant …

Objective To evaluate the efficacy and safety of recombinant human endostatin (rh-
endostatin) combined with cis-platinum for patients with malignant pleural effusions …

Objective: To evaluate and comprehensively analyze the clinical efficacy of recombinant
human endostatin combined with Iressa targeted therapy in patients with pleural metastasis …

Objective To investigate the clinical effect of recombinant human endostatin combined with
cisplatin in the treatment of malignant pleural effusion of lung cancer. Methods 100 lung …

Background: Although there are new treatments for non-small cell lung cancer with
malignant pleural effusion, these therapies are prone to recurrent pleural effusion and poor …

Purpose: To explore the efficacy and safety of thoracic hyperthermia perfusion with
recombinant human endostatin plus nedaplatin in the treatment of pleural effusion in …

Objective To observe the efficacy and safety of pleural perfusion of recombinant human
endostain (endostar) combined with cisplatin (DDP) in lung cancer patients with pleural …

Background: The aim of this study was to evaluate the efficacy and safety of recombinant
human endostatin in combination with vinorelbine+ cisplatin (NPE) for the treatment of …

Background Endostar is a new endogenous angiogenic inhibitor with implicated anti-tumor
activity. This study was to investigate whether thoracic perfusion of Endostar could be used …